Bridge City Capital’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-367,305
| Closed | -$382K | – | 111 |
|
|
2024
Q3 | $382K | Buy |
367,305
+51,296
| +16% | +$53.3K | 0.11% | 104 |
|
|
2024
Q2 | $547K | Buy |
316,009
+625
| +0.2% | +$1.08K | 0.18% | 97 |
|
|
2024
Q1 | $754K | Buy |
315,384
+2,450
| +0.8% | +$5.86K | 0.27% | 97 |
|
|
2023
Q4 | $1.04M | Buy |
312,934
+36,710
| +13% | +$122K | 0.4% | 94 |
|
|
2023
Q3 | $1.03M | Buy |
276,224
+110,048
| +66% | +$412K | 0.52% | 85 |
|
|
2023
Q2 | $710K | Buy |
166,176
+90
| +0.1% | +$384 | 0.34% | 92 |
|
|
2023
Q1 | $1.14M | Sell |
166,086
-636
| -0.4% | -$4.35K | 0.57% | 83 |
|
|
2022
Q4 | $1.32M | Sell |
166,722
-1,145
| -0.7% | -$9.07K | 0.68% | 75 |
|
|
2022
Q3 | $1.61M | Buy |
167,867
+5,721
| +4% | +$55K | 0.89% | 51 |
|
|
2022
Q2 | $1.17M | Sell |
162,146
-286
| -0.2% | -$2.07K | 0.62% | 77 |
|
|
2022
Q1 | $2.1M | Sell |
162,432
-766
| -0.5% | -$9.89K | 0.98% | 42 |
|
|
2021
Q4 | $2.61M | Sell |
163,198
-12
| -0% | -$192 | 1.07% | 41 |
|
|
2021
Q3 | $2.62M | Buy |
163,210
+4,783
| +3% | +$76.9K | 1.19% | 33 |
|
|
2021
Q2 | $2.19M | Sell |
158,427
-5,602
| -3% | -$77.5K | 0.75% | 68 |
|
|
2021
Q1 | $2.4M | Buy |
164,029
+46,298
| +39% | +$676K | 0.79% | 64 |
|
|
2020
Q4 | $2.05M | Sell |
117,731
-1,224
| -1% | -$21.3K | 0.78% | 64 |
|
|
2020
Q3 | $2.18M | Buy |
+118,955
| New | +$2.18M | 1.04% | 48 |
|